Molecular Subtype
Primary Pulmonary Myxoid Sarcoma with EWSR1-CREB1 Fusion
CI-CAN-00006517PPMSExplore in graph →
- NCIt
- C142827
Loading cancer entity…
Molecular Subtype
CI-CAN-00006517PPMSExplore in graph →
Clinical trials
1 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (0)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03600649 | Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas | unknown | Phase 1 | 50 | Salarius Pharmaceuticals, LLCINDUSTRY | 1 | Nov 21, 2023 | clinicaltrials |
Data updated 22 days agoSource updated Nov 21, 2023source: clinicaltrials